As the situation gets harder, people all over the world unite in solidarity against this virus. We all need to do our part to contribute in the fight against it, that is why we are proud to announce that Cohortias has recently signed up to collaborate in research projects to develop a vaccine.
Cohortias – Positive data from Alzheimer’s disease vaccine trial
At week six, the ACI-24.060 vaccine elicited an anti-Abeta antibody response in ABATE’s first, low dose cohort of AD patients.
